Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Item

http://www.wikidata.org/entity/Q39181445

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@en

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@nl

type

Item

label

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@en

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@nl

prefLabel

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@en

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@nl

P1476

Directed evolution of mutator adenoviruses resistant to antibody neutralization.

@en

P2093

Anshu P Gounder

http://www.w3.org/2001/XMLSchema#string

Ksenia V Skorohodova

http://www.w3.org/2001/XMLSchema#string

Nicolle D Myers

http://www.w3.org/2001/XMLSchema#string

P2860

Rates of spontaneous mutation

Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization

Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

Crystal structure of human adenovirus at 3.5 A resolution

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

Regulation of virus neutralization and the persistent fraction by TRIM21.

Postentry neutralization of adenovirus type 5 by an antihexon antibody.

Directed adenovirus evolution using engineered mutator viral polymerases.

Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors.

P304

6047-6050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00473-13

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason G Smith

P577

2013-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236043647

http://www.w3.org/2001/XMLSchema#string

P698

23487468

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

directed evolution

P932

3648140

http://www.w3.org/2001/XMLSchema#string